Navigation Links
Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance

Looking for the ultimate CHO cell culture supplement? InVitria has what scientists have been asking for! Zap-CHO is a robust CHO cell culture media supplement that improves the growth and productivity of CHO cells. Developed for scientists seeking maximum CHO cell culture performance, Zap-CHO is an animal free, well defined and consistent recombinant CHO supplement.

Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working with CHO cells can now access an informational online video featuring a presentation by Dr. Steve Pettit, InVitria’s Director of Cell Culture Product Development. Zap-CHO is a robust CHO cell supplement that maximizes CHO cell line performance and speeds-up cell line development processes. Zap-CHO is not a hydrolysate; it is an animal free, well defined and consistent recombinant CHO supplement.

Dr. Pettit guides viewers through the online video by describing the work done to test the effectiveness of Zap-CHO on CHO cell growth and productivity. “We tested Zap-CHO in the leading chemically-defined, serum- and protein-free cell culture media available on the market today,” said Dr. Pettit. “In our tests, Zap-CHO increased cell growth an average of 190% across all media and extended cell viability by delaying apoptosis. Most importantly, Zap-CHO increased volumetric productivity an average of 179%.”

In the video, Dr. Pettit points out the distinct advantages Zap-CHO gives scientists who are trying to improve their CHO cell line performance, including:

  • Faster cell growth
  • Higher peak cell density
  • Reduced apoptosis
  • Increased viability
  • Maximized productivity
  • Easy removal by Protein A chromatography during downstream purification

Further, Zap-CHO helps scientists working in clone selection by improving growth and shortening timelines; in seed train expansion by reducing the amount of time from cell bank to bioreactor; in cell adaptation by reducing the timelines for media adaptation; and, in bioproduction by maximizing antibody titre.

To watch the Zap-CHO product video click here.

To purchase Zap-CHO:
Call: 1-800-916-8311

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Mimotopes Launches Online Peptide Superstore
2. Life Science Firms are Turning to Firmex to do Deals Online
3. MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board
4. Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
5. Inspiring New Online Destination From Bayer Diabetes Care
6. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
7. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
8. MSNBC Publishes Free Online Abridgment of Biocentrism
9. Elsevier / MC Strategies Online Courses Named in the 15th Annual Communicator Awards
10. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
11. Drug Information Association Launches New 45th Annual Meeting Online
Post Your Comments:
Related Image:
Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology:
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):